BIOTRONIK Announces US Market Release for Renamic: Next Generation Programmer for Implantable Cardiac Devices

Intuitive user interface and convenient design enable efficient, versatile usage

LAKE OSWEGO, Ore. & BERLIN--(EON: Enhanced Online News)--BIOTRONIK, a leading manufacturer of implantable cardiac devices and pioneer of wireless remote monitoring technologies, announced today the US market release of Renamic, their next generation programmer for implantable cardiac devices.

“Renamic commences a new era in convenient programming and follow-up of implantable cardiac devices. BIOTRONIK appreciates and acknowledges the important input of physicians in developing Renamic’s user interface. Designed to improve daily clinic efficiency, this programmer once again exemplifies BIOTRONIK’s focus on engineering high-quality solutions for advanced patient management.”

Renamic, the latest addition to BIOTRONIK’s portfolio of external devices, is used for initial programming, reprogramming and testing of implantable pacemakers, implantable cardiac defibrillators (ICDs) and cardiac resynchronization therapy (CRT) devices. By conducting all measurements and adjustments, Renamic helps clinicians to optimize in-clinic patient care and cardiac implantable device function.

The new device’s features provide valuable benefits, such as:

• Intuitive user interface optimized to increase efficiency of patient follow-up
• Proven and tested printer from a renowned printer manufacturer
• Retractable and adjustable touchscreen for optimized viewing and handling
• Bluetooth^® enabled for external printing and data export

Jake Langer, President of BIOTRONIK USA, states, “Renamic commences a new era in convenient programming and follow-up of implantable cardiac devices. BIOTRONIK appreciates and acknowledges the important input of physicians in developing Renamic’s user interface. Designed to improve daily clinic efficiency, this programmer once again exemplifies BIOTRONIK’s focus on engineering high-quality solutions for advanced patient management.”

About BIOTRONIK SE & Co. KG

As one of the world’s leading manufacturers of cardiovascular medical devices, with several million devices implanted, BIOTRONIK is represented in over 100 countries by its global workforce of over 5,600 employees. Known for having its finger on the pulse of the medical community, BIOTRONIK assesses the challenges physicians face, and provides the best solutions for all phases of patient care, ranging from diagnosis to treatment to patient management. Quality, innovation and reliability define BIOTRONIK and its growing success, and deliver confidence and peace of mind to physicians and their patients worldwide.

More information: www.biotronik.com

Upon publication, please provide us with a copy.